Literature DB >> 21921375

Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.

Yugo Iwaya1, Kazuhiro Takenaka, Taiji Akamatsu, Yuki Yamada, Shin Haba, Kensuke Matsuda, Hideyuki Nakazawa, Takashi Muraki, Yasunori Kaneko, Toshiro Ito, Kenji Sano, Norikazu Arakura, Eiji Tanaka, Fumihiro Ishida.   

Abstract

A 38-year-old man presented to our hospital with abdominal pain and melena. Gastrointestinal endoscopy revealed a large gastric ulcer, and the pathological diagnosis of diffuse large B-cell lymphoma (DLBCL) was made based on immunohistochemical findings. Left diplopia developed soon after commencement of chemotherapy. Despite normal findings from head MRI, orbital involvement in DLBCL was detected with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). The patient was treated with salvage chemotherapy with success. Treatment analysis using FDG-PET for patients with DLBCL, especially for those with clinical symptoms and negative findings on conventional modalities, may be useful for assessing disease status and adjusting treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921375     DOI: 10.2169/internalmedicine.50.5524

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Ileo-ileal intussusception caused by diffuse large B-cell lymphoma of the ileum.

Authors:  Xie-Qun Xu; Tao Hong; Bing-Lu Li; Wei Liu
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Value of (18)F-FDG-PET/CT in ocular sebaceous adenocarcinoma: a case report and literature review.

Authors:  Xin Zhao; Guang-Fa Wang; Kui Zhao; Hong-Guang Cui; Wei Ding
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  18F-fluorodeoxyglucose positron emission tomography/computed tomography findings of gastric lymphoma: Comparisons with gastric cancer.

Authors:  Jiang Wu; Hong Zhu; Kai Li; Xin-Gang Wang; Yi Gui; Guang-Ming Lu
Journal:  Oncol Lett       Date:  2014-08-04       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.